The QMN Weekly Bulletin

FDA: Sun’s Caraco Can Resume Some Operations at Two Michigan Facilities

Aug. 31, 2012
A A
Sun Pharmaceuticals’ Caraco unit may resume some of its Detroit and Wixom, Mich., operations after recent FDA inspections show it is in compliance with a 2009 consent decree. The decree relates specifically to production of Caraco’s heart failure drug carvedilol and antibiotic paramomycin.
Drug Industry Daily